| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |